CPDA-1 2.23 g/70mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 2.23 g/70mL

CPDA-1 2.23 g/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, ensuring blood viability during storage.

Strength

2.23 g/70mL

Pack Size

70 mL in 1 BAG (0942-6312-04)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 2.23 g/70mL is primarily used to prevent blood clotting during storage. It is commonly employed in blood banks and medical facilities to extend the shelf life of stored blood. The solution helps maintain the quality and viability of blood components, making it essential for transfusions and medical procedures requiring preserved blood.

Side Effects

When administered intravenously, CPDA-1 2.23 g/70mL works by binding calcium ions, which are necessary for the clotting process. This action helps keep the blood in a liquid state, ensuring it remains usable for transfusions. The solution also provides nutrients that support the metabolic needs of blood cells during storage.

Precautions & Warnings

CPDA-1 2.23 g/70mL should be handled with care to maintain sterility. It is important to follow proper storage guidelines to ensure the solution remains effective. Always check the expiration date and inspect the solution for any signs of contamination before use.

Avoid Interactions

CPDA-1 2.23 g/70mL may interact with certain medications or substances that affect blood clotting. It is important to consult with a healthcare provider before using this solution, especially if you are taking other medications that impact blood coagulation.

Frequently Asked Questions

CPDA-1 2.23 g/70mL is used to preserve blood components by preventing clotting during storage.

It works by binding calcium ions, which are essential for the clotting process, keeping the blood in a liquid state.

Consult a healthcare provider before using CPDA-1 2.23 g/70mL with other medications, especially those affecting blood coagulation.

Follow proper storage guidelines to maintain the solution's effectiveness and sterility.

The solution contains citrate, phosphate, dextrose, and adenine, which help preserve blood components.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.